The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation
Takashi Imai1, Juan Lin2, Göksu Gökberk Kaya1
1Institute for Genetics, University of Cologne, 50674 Cologne, Germany; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.
Abstract:
RIPK1 is a multi-functional kinase that regulates cell death and inflammation and has been implicated in the pathogenesis of inflammatory diseases. RIPK1 acts in a kinase-dependent and kinase-independent manner to promote or suppress apoptosis and necroptosis, but the underlying mechanisms remain poorly understood. Here, we show that a mutation (R588E) disrupting the RIPK1 death domain (DD) caused perinatal lethality induced by ZBP1-mediated necroptosis. Additionally, these mice developed postnatal inflammatory pathology, which was mediated by necroptosis-independent TNFR1, TRADD, and TRIF signaling, partially requiring RIPK3. Our biochemical mechanistic studies revealed that ZBP1- and TRIF-mediated activation of RIPK3 required RIPK1 kinase activity in wild-type cells but not in Ripk1R588E/R588E cells, suggesting that DD-dependent oligomerization of RIPK1 and its interaction with FADD determine the mechanisms of RIPK3 activation by ZBP1 and TRIF. Collectively, these findings revealed a critical physiological role of DD-dependent RIPK1 signaling that is important for the regulation of tissue homeostasis and inflammation.
Insights
A mutation in RIPK1’s death domain (DD) caused lethal necroptosis in mice. This RIPK1 signaling is crucial for regulating inflammation and maintaining tissue homeostasis.
Area of Science:
- Molecular Biology
- Immunology
- Cell Biology
Background:
- Receptor-interacting protein kinase 1 (RIPK1) is a key regulator of cell death pathways, including apoptosis and necroptosis.
- Its precise roles in kinase-dependent and -independent signaling remain incompletely understood.
- Dysregulation of RIPK1 is implicated in inflammatory diseases.
Purpose of the Study:
- To elucidate the physiological function of the RIPK1 death domain (DD) in regulating cell death and inflammation.
- To investigate the mechanisms by which RIPK1 controls RIPK3 activation by ZBP1 and TRIF.
- To determine the role of RIPK1 signaling in tissue homeostasis.
Main Methods:
- Generation and analysis of mice with a mutation (R588E) in the RIPK1 death domain.
- Biochemical assays to study RIPK1 kinase activity and protein interactions.
- Investigation of necroptosis and inflammatory signaling pathways (ZBP1, TNFR1, TRIF, RIPK3, FADD).
Main Results:
- Mice with the Ripk1 R588E mutation exhibited perinatal lethality due to ZBP1-mediated necroptosis.
- These mice also developed postnatal inflammatory pathology independent of necroptosis, involving TNFR1, TRADD, and TRIF signaling, partially dependent on RIPK3.
- RIPK1 kinase activity was essential for ZBP1- and TRIF-mediated RIPK3 activation in wild-type cells, but not in Ripk1R588E/R588E cells, indicating DD-dependent mechanisms.
Conclusions:
- The RIPK1 death domain is critical for preventing lethal necroptosis and regulating postnatal inflammation.
- DD-dependent RIPK1 oligomerization and FADD interaction dictate RIPK3 activation mechanisms.
- RIPK1 signaling is vital for maintaining tissue homeostasis and controlling inflammatory responses.
Related Concept Videos
Regulation of the Unfolded Protein Response
The JAK-STAT Signaling Pathway
The Extrinsic Apoptotic Pathway
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
The Intrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...


